5Major FJ. Blessing JA, Silverberg SG et al. Prognostic factors in early -stage Uterine sarcoma. A Gynecologic Oncology group study. Cancer Suppl, 2003, 81 (11): 1 702. 被引量：1
6Piua B, Abinvich A, Anai Z et al. Uterine sarcoma in the south of Israel: study of 36cases. J Surg Oncol, 2001 , 68 ( l ) : 55. 被引量：1
7Olah KS, Dunn JA, Gee H. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumos when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma. Br J Obstet Gynecol, 2002, 109 (4) : 590. 被引量：1
8Resnik E, Chamber SK, Carcangiu ML et al. A phase Ⅱ study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed mullerrian tumors (MMt)of the uterus. Gynecol Oncol 2003, 64 (4): 370. 被引量：1
9Moskovic V, Macsweeney E, Law Met al. Survival patterns of spread and prognostic factors in uterine sarcoma; a study of 76 patients. Br J radiol, 2003, 76 (11): 1 009. 被引量：1
10Ayhan A, Tuncer ZS, Tanir M et al. Uterine sarcoma: the Hacettepe hospital experience of 88 consecutive patients. Eur J Gynecol Oncol,2004, 27 (2): 146. 被引量：1
